From: Surgical management and outcome of synovial sarcoma in the spine
 | Spinal SS, n = 16 |
---|---|
Sex, M/F | 11/5 |
Age, ≤ 30/> 30 | 8/8 |
Preoperative KPS, < 60/60–80/≥ 80 | 12/4/0 |
Preoperative Frankel scores, A–C/D–E | 7/9 |
Preoperative VAS scores, ≤ 5/> 5 | 6/10 |
Tumour size (mean ± SD, cm) | 7.57 ± 3.33 |
Recurrent or metastasis lesions, no/yes | 8/8 |
Preoperative chemotherapy, no/yes | 13/3 |
Operation time (mean ± SD, min) | 292.9 ± 121.2 |
Intraoperative blood loss (mean ± SD, ml) | 1547 ± 1152.8 |
Complication, no/yes | 15/1 |
Postoperative recurrence, no/yes | 12/4 |
Postoperative distant metastasis, no/yes | 13/3 |
Adjuvant chemotherapy, no/yes | 10/6 |
Adjuvant radiotherapy, no/yes | 10/6 |